| Year |
Citation |
Score |
| 2024 |
Camacho-Hernandez GA, Gopinath A, Okorom AV, Khoshbouei H, Newman AH. Development of a Fluorescently Labeled Ligand for Rapid Detection of DAT in Human and Mouse Peripheral Blood Monocytes. Jacs Au. 4: 657-665. PMID 38425927 DOI: 10.1021/jacsau.3c00719 |
0.38 |
|
| 2023 |
Bu M, Follett J, Deng I, Tatarnikov I, Wall S, Guenther D, Maczis M, Wimsatt G, Milnerwood A, Moehle MS, Khoshbouei H, Farrer MJ. Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice. Npj Parkinson's Disease. 9: 167. PMID 38110354 DOI: 10.1038/s41531-023-00609-7 |
0.379 |
|
| 2023 |
Gopinath A, Riaz T, Miller E, Phan L, Smith A, Syed O, Franks S, Martinez LR, Khoshbouei H. Methamphetamine induces a low dopamine transporter expressing immunophenotype without altering total number of peripheral immune cells. Basic & Clinical Pharmacology & Toxicology. PMID 36710070 DOI: 10.1111/bcpt.13838 |
0.366 |
|
| 2023 |
Gopinath A, Mackie PM, Phan LT, Mirabel R, Smith AR, Miller E, Franks S, Syed O, Riaz T, Law BK, Urs N, Khoshbouei H. Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune Responses. Cells. 12. PMID 36672204 DOI: 10.3390/cells12020269 |
0.382 |
|
| 2022 |
Gaskill PJ, Khoshbouei H. Dopamine and norepinephrine are embracing their immune side and so should we. Current Opinion in Neurobiology. 77: 102626. PMID 36058009 DOI: 10.1016/j.conb.2022.102626 |
0.717 |
|
| 2022 |
Hansen CA, Miller DR, Annarumma S, Rusch CT, Ramirez-Zamora A, Khoshbouei H. Levodopa-induced dyskinesia: a historical review of Parkinson's disease, dopamine, and modern advancements in research and treatment. Journal of Neurology. PMID 35039902 DOI: 10.1007/s00415-022-10963-w |
0.521 |
|
| 2022 |
Mackie PM, Gopinath A, Montas DM, Nielsen A, Smith A, Nolan RA, Runner K, Matt SM, McNamee J, Riklan JE, Adachi K, Doty A, Ramirez-Zamora A, Yan L, Gaskill PJ, ... ... Khoshbouei H, et al. Functional characterization of the biogenic amine transporters on human macrophages. Jci Insight. PMID 35015729 DOI: 10.1172/jci.insight.151892 |
0.705 |
|
| 2021 |
Miller DR, Bu AM, Gopinath A, Martinez LR, Khoshbouei H. . The Journal of Pharmacology and Experimental Therapeutics. PMID 34535563 DOI: 10.1124/jpet.121.000767 |
0.605 |
|
| 2021 |
Dagra A, Miller DR, Lin M, Gopinath A, Shaerzadeh F, Harris S, Sorrentino ZA, Støier JF, Velasco S, Azar J, Alonge AR, Lebowitz JJ, Ulm B, Bu M, Hansen CA, ... ... Khoshbouei H, et al. α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability. Npj Parkinson's Disease. 7: 76. PMID 34408150 DOI: 10.1038/s41531-021-00210-w |
0.627 |
|
| 2021 |
Gopinath A, Badov M, Francis M, Shaw G, Collins A, Miller DR, Hansen CA, Mackie P, Tansey MG, Dagra A, Madorsky I, Ramirez-Zamora A, Okun MS, Streit WJ, Khoshbouei H. Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes. Npj Parkinson's Disease. 7: 68. PMID 34341346 DOI: 10.1038/s41531-021-00212-8 |
0.492 |
|
| 2021 |
Gopinath A, Badov M, Francis M, Shaw G, Collins A, Miller DR, Hansen CA, Mackie P, Tansey MG, Dagra A, Madorsky I, Ramirez-Zamora A, Okun MS, Streit WJ, Khoshbouei H. TNFα increases tyrosine hydroxylase expression in human monocytes. Npj Parkinson's Disease. 7: 62. PMID 34285243 DOI: 10.1038/s41531-021-00201-x |
0.542 |
|
| 2021 |
Lin M, Mackie PM, Shaerzadeh F, Gamble-George J, Miller DR, Martyniuk CJ, Khoshbouei H. In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition. Acta Neuropathologica Communications. 9: 107. PMID 34099060 DOI: 10.1186/s40478-021-01203-9 |
0.618 |
|
| 2021 |
Hiller H, Beachy DE, Lebowitz JJ, Engler S, Mason JR, Miller DR, Kusmarteva I, Jacobsen LM, Posgai AL, Khoshbouei H, Oram RA, Schatz DA, Hattersley AT, Bodenmiller B, Atkinson MA, et al. Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes. Diabetes. PMID 34035041 DOI: 10.2337/db21-0070 |
0.454 |
|
| 2021 |
Miller D, Guenther DT, Maurer AP, Hansen CA, Zalesky A, Khoshbouei H. Dopamine transporter is a master regulator of dopaminergic neural network connectivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33980544 DOI: 10.1523/JNEUROSCI.0223-21.2021 |
0.59 |
|
| 2021 |
Pino JA, Nuñez-Vivanco G, Hidalgo G, Reyes Parada M, Khoshbouei H, Torres GE. Identification of Critical Residues in the Carboxy Terminus of the Dopamine Transporter Involved in the G Protein βγ-Induced Dopamine Efflux. Frontiers in Pharmacology. 12: 642881. PMID 33841159 DOI: 10.3389/fphar.2021.642881 |
0.409 |
|
| 2021 |
Bu M, Farrer MJ, Khoshbouei H. Dynamic control of the dopamine transporter in neurotransmission and homeostasis. Npj Parkinson's Disease. 7: 22. PMID 33674612 DOI: 10.1038/s41531-021-00161-2 |
0.425 |
|
| 2020 |
Miller DR, Khoshbouei H, Garai S, Cantwell LN, Stokes C, Thakur G, Papke RL. Allosterically Potentiated α7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium. Molecular Pharmacology. PMID 33020143 DOI: 10.1124/molpharm.120.000012 |
0.469 |
|
| 2020 |
Lin M, Colon-Perez LM, Sambo DO, Miller DR, Lebowitz JJ, Jimenez-Rondan F, Cousins RJ, Horenstein N, Aydemir TB, Febo M, Khoshbouei H. Mechanism of manganese dysregulation of dopamine neuronal activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32576620 DOI: 10.1523/Jneurosci.2830-19.2020 |
0.685 |
|
| 2020 |
Shaerzadeh F, Phan L, Miller D, Dacquel M, Hachmeister W, Hansen C, Bechtle A, Tu D, Martcheva M, Foster TC, Kumar A, Streit WJ, Khoshbouei H. Microglia senescence occurs in both substantia nigra and ventral tegmental area. Glia. PMID 32275335 DOI: 10.1002/Glia.23834 |
0.643 |
|
| 2020 |
Streit WJ, Khoshbouei H, Bechmann I. Dystrophic microglia in late-onset Alzheimer's disease. Glia. PMID 31922322 DOI: 10.1002/Glia.23782 |
0.303 |
|
| 2019 |
Koutzoumis DN, Vergara M, Pino J, Buddendorff J, Khoshbouei H, Mandel RJ, Torres GE. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease. Experimental Neurology. 113159. PMID 31843492 DOI: 10.1016/J.Expneurol.2019.113159 |
0.402 |
|
| 2019 |
Lebowitz JJ, Khoshbouei H. Heterogeneity of dopamine release sites in health and degeneration. Neurobiology of Disease. 134: 104633. PMID 31698055 DOI: 10.1016/J.Nbd.2019.104633 |
0.541 |
|
| 2019 |
Gopinath A, Doty A, Mackie PM, Hashimi B, Francis M, Saadatpour L, Saha K, Shaw G, Ramirez-Zamora A, Okun MS, Streit WJ, Khoshbouei H. A novel approach to study markers of dopamine signaling in peripheral immune cells. Journal of Immunological Methods. 112686. PMID 31634479 DOI: 10.1016/J.Jim.2019.112686 |
0.484 |
|
| 2019 |
Miller DR, Lebowitz JJ, Guenther DT, Refowich AJ, Hansen C, Maurer AP, Khoshbouei H. Methamphetamine regulation of activity and topology of ventral midbrain networks. Plos One. 14: e0222957. PMID 31536584 DOI: 10.1371/Journal.Pone.0222957 |
0.576 |
|
| 2019 |
Nickoloff EA, Mackie P, Runner K, Matt SM, Khoshbouei H, Gaskill PJ. Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway. Brain, Behavior, and Immunity. PMID 31470080 DOI: 10.1016/J.Bbi.2019.08.191 |
0.756 |
|
| 2019 |
Ahmari N, Santisteban MM, Miller DR, Geis NM, Larkin RM, Redler TL, Denson H, Khoshbouei H, Baekey DM, Raizada MK, Zubcevic J. Elevated bone marrow sympathetic drive precedes systemic inflammation in angiotensin II hypertension. American Journal of Physiology. Heart and Circulatory Physiology. PMID 31150271 DOI: 10.1152/Ajpheart.00510.2018 |
0.554 |
|
| 2019 |
Lebowitz JJ, Pino JA, Mackie PM, Lin M, Hurst C, Divita K, Collins AT, Koutzoumis DN, Torres GE, Khoshbouei H. Clustered Kv2.1 decreases dopamine transporter activity and internalization. The Journal of Biological Chemistry. PMID 30824538 DOI: 10.1074/Jbc.Ra119.007441 |
0.503 |
|
| 2018 |
Shaerzadeh F, Streit WJ, Heysieattalab S, Khoshbouei H. Methamphetamine neurotoxicity, microglia, and neuroinflammation. Journal of Neuroinflammation. 15: 341. PMID 30541633 DOI: 10.1186/S12974-018-1385-0 |
0.448 |
|
| 2018 |
Salvatore MF, Nejtek VA, Khoshbouei H. Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine. Neurotoxicology. PMID 29782882 DOI: 10.1016/J.Neuro.2018.05.003 |
0.47 |
|
| 2018 |
Miller DR, Shaerzadeh F, Phan L, Sharif N, Gamble-George J, McLaughlin JP, Streit WJ, Khoshbouei H. HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Glia. PMID 29733459 DOI: 10.1002/Glia.23447 |
0.669 |
|
| 2018 |
Colon-Perez LM, Pino JA, Saha K, Pompilus M, Kaplitz S, Choudhury N, Jagnarine DA, Geste JR, Levin BA, Wilks I, Setlow B, Bruijnzeel AW, Khoshbouei H, Torres GE, Febo M. Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone. Neuropharmacology. PMID 29729891 DOI: 10.1016/J.Neuropharm.2018.04.031 |
0.42 |
|
| 2018 |
Mackie P, Lebowitz J, Saadatpour L, Nickoloff E, Gaskill P, Khoshbouei H. The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease. Brain, Behavior, and Immunity. PMID 29551693 DOI: 10.1016/J.Bbi.2018.03.020 |
0.761 |
|
| 2018 |
Sambo DO, Lebowitz JJ, Khoshbouei H. The Sigma-1 Receptor as a Regulator of Dopamine Neurotransmission: A Potential Therapeutic Target for Methamphetamine Addiction. Pharmacology & Therapeutics. PMID 29360540 DOI: 10.1016/J.Pharmthera.2018.01.009 |
0.483 |
|
| 2017 |
Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, Katz J, Yan L, Febo M, Henry LK, Bruijnzeel AW, ... ... Khoshbouei H, et al. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nature Communications. 8: 2228. PMID 29263318 DOI: 10.1038/S41467-017-02087-X |
0.712 |
|
| 2017 |
Siciliano CA, Saha K, Calipari ES, Fordahl SC, Chen R, Khoshbouei H, Jones SR. Amphetamine reverses escalated cocaine intake via restoration of dopamine transporter conformation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29175958 DOI: 10.1523/Jneurosci.2604-17.2017 |
0.331 |
|
| 2017 |
Khare S, Nick JA, Zhang Y, Galeano K, Butler B, Khoshbouei H, Rayaprolu S, Hathorn T, Ranum LPW, Smithson L, Golde TE, Paucar M, Morse R, Raff M, Simon J, et al. A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking. Plos One. 12: e0173565. PMID 28467418 DOI: 10.1371/Journal.Pone.0173565 |
0.302 |
|
| 2017 |
Gaskill P, Miller D, George JG, Yano H, Khoshbouei H. HIV, Tat and dopaminergic transmission. Neurobiology of Disease. PMID 28457951 DOI: 10.1016/J.Nbd.2017.04.015 |
0.733 |
|
| 2016 |
Lin M, Sambo D, Khoshbouei H. Methamphetamine Regulation of Firing Activity of Dopamine Neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 10376-10391. PMID 27707972 DOI: 10.1523/Jneurosci.1392-16.2016 |
0.513 |
|
| 2016 |
Butler B, Sambo D, Khoshbouei H. Alpha-synuclein modulates dopamine neurotransmission. Journal of Chemical Neuroanatomy. PMID 27334403 DOI: 10.1016/J.Jchemneu.2016.06.001 |
0.378 |
|
| 2016 |
Heysieattalab S, Naghdi N, Hosseinmardi N, Zarrindast MR, Haghparast A, Khoshbouei H. Methamphetamine-Induced Enhancement of Hippocampal LTP Is Modulated by NMDA and GABA Receptors in the Shell-Accumbens. Synapse (New York, N.Y.). PMID 27029021 DOI: 10.1002/Syn.21905 |
0.356 |
|
| 2016 |
Richardson BD, Saha K, Krout D, Cabrera E, Felts B, Henry LK, Swant J, Zou MF, Newman AH, Khoshbouei H. Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane. Nature Communications. 7: 10423. PMID 26804245 DOI: 10.1038/Ncomms10423 |
0.646 |
|
| 2015 |
Heysieattalab S, Naghdi N, Zarrindast MR, Haghparast A, Mehr SE, Khoshbouei H. The effects of GABAA and NMDA receptors in the shell-accumbens on spatial memory of METH-treated rats. Pharmacology, Biochemistry, and Behavior. PMID 26708956 DOI: 10.1016/J.Pbb.2015.12.008 |
0.315 |
|
| 2015 |
Butler B, Saha K, Rana T, Becker JP, Sambo D, Davari P, Goodwin JS, Khoshbouei H. Dopamine Transporter Activity Is Modulated by α-Synuclein. The Journal of Biological Chemistry. PMID 26442590 DOI: 10.1074/Jbc.M115.691592 |
0.456 |
|
| 2015 |
Butler B, Goodwin S, Saha K, Becker J, Sambo D, Davari P, Khoshbouei H. Dopamine transporter activity is modulated by α-synuclein. The Journal of Biological Chemistry. 290: 19009. PMID 26232401 DOI: 10.1074/jbc.A115.639880 |
0.303 |
|
| 2015 |
Butler B, Goodwin S, Saha K, Becker J, Sambo D, Davari P, Khoshbouei H. Dopamine Transporter Activity Is Modulated by α-synuclein. The Journal of Biological Chemistry. PMID 26048988 DOI: 10.1074/jbc.M115.639880 |
0.326 |
|
| 2014 |
Saha K, Sambo D, Richardson BD, Lin LM, Butler B, Villarroel L, Khoshbouei H. Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing. The Journal of Biological Chemistry. 289: 22246-57. PMID 24962577 DOI: 10.1074/Jbc.M114.563056 |
0.708 |
|
| 2013 |
Roth JA, Li Z, Sridhar S, Khoshbouei H. The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. Neurotoxicology. 35: 121-8. PMID 23313730 DOI: 10.1016/J.Neuro.2013.01.002 |
0.508 |
|
| 2012 |
Saha K, Swant J, Khoshbouei H. Single cell measurement of dopamine release with simultaneous voltage-clamp and amperometry. Journal of Visualized Experiments : Jove. PMID 23207721 DOI: 10.3791/3798 |
0.515 |
|
| 2012 |
Butler B, Saha K, Khoshbouei H. α-synuclein regulation of dopamine transporter Translational Neuroscience. 3: 249-257. DOI: 10.2478/S13380-012-0036-7 |
0.499 |
|
| 2011 |
Swant J, Goodwin JS, North A, Ali AA, Gamble-George J, Chirwa S, Khoshbouei H. α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. The Journal of Biological Chemistry. 286: 43933-43. PMID 21990355 DOI: 10.1074/Jbc.M111.241232 |
0.554 |
|
| 2010 |
Swant J, Chirwa S, Stanwood G, Khoshbouei H. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. Plos One. 5: e11382. PMID 20614033 DOI: 10.1371/Journal.Pone.0011382 |
0.35 |
|
| 2010 |
Goodwin JS, Patel T, Kenworthy AK, Khoshbouei H. Psychostimulants Affect Dopamine Transporter Lateral Mobility and Membrane Microdomain Distribution Biophysical Journal. 98: 3-6. DOI: 10.1016/J.Bpj.2009.12.1666 |
0.414 |
|
| 2009 |
Goodwin JS, Larson GA, Swant J, Sen N, Javitch JA, Zahniser NR, De Felice LJ, Khoshbouei H. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. The Journal of Biological Chemistry. 284: 2978-89. PMID 19047053 DOI: 10.1074/Jbc.M805298200 |
0.514 |
|
| 2008 |
Lute BJ, Khoshbouei H, Saunders C, Sen N, Lin RZ, Javitch JA, Galli A. PI3K signaling supports amphetamine-induced dopamine efflux. Biochemical and Biophysical Research Communications. 372: 656-61. PMID 18510945 DOI: 10.1016/J.Bbrc.2008.05.091 |
0.762 |
|
| 2006 |
Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron. 51: 417-29. PMID 16908408 DOI: 10.1016/J.Neuron.2006.06.028 |
0.784 |
|
| 2005 |
Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proceedings of the National Academy of Sciences of the United States of America. 102: 3495-500. PMID 15728379 DOI: 10.1073/Pnas.0407737102 |
0.642 |
|
| 2004 |
Gnegy ME, Khoshbouei H, Berg KA, Javitch JA, Clarke WP, Zhang M, Galli A. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Molecular Pharmacology. 66: 137-43. PMID 15213305 DOI: 10.1124/Mol.66.1.137 |
0.623 |
|
| 2004 |
Khoshbouei H, Sen N, Guptaroy B, Johnson L', Lund D, Gnegy ME, Galli A, Javitch JA. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. Plos Biology. 2: E78. PMID 15024426 DOI: 10.1371/Journal.Pbio.0020078 |
0.609 |
|
| 2003 |
Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. The Journal of Biological Chemistry. 278: 12070-7. PMID 12556446 DOI: 10.1074/Jbc.M212815200 |
0.625 |
|
| Show low-probability matches. |